2007
DOI: 10.1016/j.yjmcc.2007.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
58
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 74 publications
(62 citation statements)
references
References 26 publications
3
58
0
Order By: Relevance
“…Indeed, an association between glucose-induced damage in endothelial cells and altered vasoactive factors, such as increased ET-1 expression and decreased NO bioavailability, has already been shown previously [4]. Furthermore, MMP-2 is colocalized with caveolae on the endothelial cells [47], while Cav-1 overexpression can lead to a decrease in MMP-2 activity [48]. Therefore, an increased Cav-1 level and decreased levels of MMP-2 and MMP-9 in aortas from diabetic rats are supporting the above hypothesis.…”
Section: Discussionmentioning
confidence: 84%
See 1 more Smart Citation
“…Indeed, an association between glucose-induced damage in endothelial cells and altered vasoactive factors, such as increased ET-1 expression and decreased NO bioavailability, has already been shown previously [4]. Furthermore, MMP-2 is colocalized with caveolae on the endothelial cells [47], while Cav-1 overexpression can lead to a decrease in MMP-2 activity [48]. Therefore, an increased Cav-1 level and decreased levels of MMP-2 and MMP-9 in aortas from diabetic rats are supporting the above hypothesis.…”
Section: Discussionmentioning
confidence: 84%
“…6 Schematic illustration for the putative mechanisms leading to diabetic endothelial vascular dysfunction. Sustained hyperglycemia causes several alterations in vasculature including its direct effect on increase in oxidative stress as well as decrease in antioxidant defence system [3, 7-10, 15, 16, 22, 32-35, 37, 39-41], changes in function and density of receptors [7,10,13,17,23,31,40], increased expression levels of Cav-1 [5,6,23,31,47,48], ET-1 [4,13,33], activation of PKC [10, 39-42, 45, 46], and degradation of MMPs [11,12,15,16,43,[47][48][49]. In addition, according to literature, most of these components are also affected with increased oxidative stress and unbalanced oxidants/antioxidants ratio, as well as altered cellular redox state.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Williams et al reported that overexpression of Cav1 in metastatic breast cancer cells reduced cell invasion capacity, which might be mediated partly through inhibition of MMP2 and MMP9 activities [22]. Moreover, Chow et al found the colocalization of MMP2 and Cav1 on the plasma membrane of cardiomyocytes and Cav1 interacted with MMP2 via its scaffolding domain, which was responsible for the inhibition of MMP2 activity in the heart [23]. However, whether Cav1 directly regulates the activity of MMP2, or whether other signal molecules participate in this process, needs further investigations.…”
Section: Discussionmentioning
confidence: 99%
“…The activation of MMP2 increases SMC proliferation and migration. Importantly, membrane type 1-MMP, a physiological activator of pro-MMP2, is preferentially localized in caveolae, and caveolin-1 negatively regulates membrane type 1-MMP and MMP2 activity and inhibits cell migration (4,19,92). The increased expression and activity of MMP2 in the presence of enhanced expression of caveolin-1 in SMCs suggest that caveolin-1 has lost its inhibitory function.…”
Section: Enhanced Expression Of Caveolin-1 In Smcs Loss Of Endothelimentioning
confidence: 99%